<mods:mods version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mods="http://www.loc.gov/mods/v3"><mods:titleInfo><mods:title>TIZIMLI SKLERODERMIYA: PATOGENEZ, KLINIK KECHISH, DIAGNOSTIKA VA DAVOLASHNING ZAMONAVIY YONDASHUVLARI</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">Eshmoʻminova</mods:namePart><mods:namePart type="family">Jasmina</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">Jumayeva</mods:namePart><mods:namePart type="family">Nozima</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">Bo‘riyeva</mods:namePart><mods:namePart type="family">Dilnoza</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>Tizimli sklerodermiya, ya’ni tizimli skleroz, kam uchraydigan, ammo ko‘p a’zoli shikastlanish bilan kechadigan autoimmun biriktiruvchi to‘qima kasalligidir. Kasallikning markazida uchta yirik patobiologik halqa – immun tizimining disbalansi, mikrotomirlar zararlanishi va fibroblastlar faolligining oshishi natijasida kollagenning ortiqcha to‘planishi turadi.&amp;nbsp;</mods:abstract><mods:originInfo><mods:dateIssued encoding="iso8601">2026-04-25</mods:dateIssued></mods:originInfo><mods:originInfo><mods:publisher>Research Science and Innovation House</mods:publisher></mods:originInfo><mods:genre>Maqola</mods:genre></mods:mods>